Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome
A 6-month Randomized, Controlled, Open-label, 2-arm Parallel Group, Multicenter Study to Evaluate the Effect of Switching From Cigarette Smoking to the Use of IQOS in Smokers With Generalized Chronic Periodontitis on the Response to Mechanical Periodontal Treatment and Oral Health Status.
Sponsor: Philip Morris Products S.A.
Listed as NCT03364751, this NA trial focuses on Chronic Periodontitis and Gingival Diseases and remains completed. Sponsored by Philip Morris Products S.A., it has been updated 13 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2023 — Jul 2024 [monthly]
Completed NA
-
Mar 2021 — Feb 2023 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Completed NA
-
Jul 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2019 — Jul 2019 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
-
Dec 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Philip Morris Products S.A.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bunkyō, Japan , Chikusei, Japan , Chiyoda City, Japan , Chōfu, Japan , Chūō, Japan , Fukuoka, Japan , Futtsu, Japan , Himi, Japan , Kagoshima, Japan , Kawaguchi, Japan and 11 more locations